The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer
From BugSigDB
Study information
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Katayama Y, Yamada T, Shimamoto T, Iwasaku M, Kaneko Y, Uchino J, Takayama K
Journal
Translational lung cancer research
Year
2019
Keywords:
Immunotherapy, gut microbiome, non-small cell lung cancer (NSCLC), retrospective analysis